ATYR
aTyr Pharma
ATYR
ATYR
41 hedge funds and large institutions have $105M invested in aTyr Pharma in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $154M → $105M (-$48.5M)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
63% less call options, than puts
Call options by funds: $445K | Put options by funds: $1.2M
Holders
41
Holding in Top 10
1
Calls
$445K
Puts
$1.2M
Top Buyers
| 1 | +$669K | |
| 2 | +$565K | |
| 3 | +$459K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$407K |
| 5 |
State Street
Boston,
Massachusetts
|
+$144K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$1.35M | |
| 3 | -$1.14M | |
| 4 |
Two Sigma Advisers
New York
|
-$1.02M |
| 5 |
VA
VR Adviser
New York
|
-$889K |